Amplification of melana messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma

British Journal of Dermatology

Volumn 141, Issue 1, 1999, Pages 30-36

  Schittek, Birgit ^a   Bodingbauer, Y ^a   Ellwanger, U ^a   Blaheta, H J ^a   Garbe, C ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Malignant melanoma; MelanA; Micrometastases; Peripheral blood marker; Reverse transcription polymerase chain reaction; Tyrosinase

Indexed keywords

MELAN A; TUMOR MARKER; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM CIRCULATING CELLS; NEOPLASM PROTEINS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 0032816379     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02917.x     Document Type: Article

References (31)

1. Naito H, Kuzumaki N, Uchino J et al. Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer 1991; 27: 762-5.
2. Mattano LA Jr, Moss TJ, Emerson SG. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 1992; 52: 4701-5.
3. Datta YH, Adams PT, Drobyski WR et al. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polyreaction. J Clin Oncol 1994; 12: 475-82.
4. Moreno JG, Croce CM, Fischer R et al. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 1992; 52: 6110-12.
5. Seiden MV, Kantoff PW, Krithivas K et al. Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 1994; 12: 2614-9.
6. Matsumura M, Niwa Y, Hikiba Y et al. Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alphafetoprotein mRNA) in blood. Biochem Biophys Res Commun 1995; 207: 813-18.
7. Hillaire S, Barbu V, Boucher E et al. Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma. Gastroenterology 1994; 106: 239-42.
8. Gerhard M, Juhl H, Kalthoff H et al. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994; 12: 725-9.
9. Buzaid AC, Balch CM. Polymerase chain reaction for detection of melanoma in peripheral blood: Too early to assess clinical value. J Natl Cancer Inst 1996; 88: 569-70.
10. Ghossein RA, Rosai J. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 1996; 78: 10-16.
11. Battayani Z, Grob JJ, Xerri L et al. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 1995; 131: 443-7.
12. Brossart P, Keilholz U, Scheibenbogen C et al. Detection of residual tumor cells in patients with malignant melanoma responding to immunotherapy. J Immunother 1994; 15: 38-41.
13. Brossart P, Keilholz U, Willhauck M et al. Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 1993; 101: 887-9.
14. Brossart P, Schmier JW, Kruger S et al. A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 1995; 55: 4065-8.
15. Curry BJ, Smith MJ, Hersey P. Detection and quantitation of melanoma cells in the circulation of patients. Melanoma Res 1996; 6: 45-54.
16. Foss AJ, Guille MJ, Occleston NL et al. The detection of melanoma cells in peripheral blood by reverse transcript ion-polymerase chain reaction. Br J Cancer 1995; 72: 155-9.
17. Hoon DS, Wang Y, Dale PS et al. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 1995; 13: 2109-16.
18. Mellado B, Colomer D, Castel T et al. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant mealnoma: Association with clinical stage and prognosis. J Clin Oncol 1996; 14: 2091-7.
19. Smith B, Selby P, Southgate J et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 118: 1227-9.
20. Kunter U, Buer J, Probst M et al. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 1997; 88: 590-4.
21. Glaser R, Rass K, Seiter S et al. Detection of circulating melanoma cells by speficic amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: A clinical two-center study. J Clin Oncol 1997; 15: 2818-25.
22. Jung FA, Buzaid AC, Ross MI et al. Evaluation tyrosinase mRNA as a tumor marker in the blood of melanoma patients. J Clin Oncol 1997; 15: 2826-31.
23. Reinhold U, Ludtke Handjery HC, Schnautz S et al. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastasis tumor progression. J Invest Dermatol 1997; 108: 166-9.
24. Farthmann B, Eberle J, Krasagakis K et al. RT PCR for tyrosinase-mRNA-positive cells in peripheral blood: Evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J Invest Dermatol 1998; 110: 263-7.
25. Ghossein RA, Coil D, Brennan M et al. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clin Cancer Res 1998; 4: 419-28.
26. Schittek B, Blaheta H-J, Flörchinger G et al. Increased sensitivity for the detection of malignant melanoma cells in peripheral blood using an improved protocol for reverse transcription polymerase chain reaction. Br J Dermatol 1999; 141: 37-43.
27. Curry BJ, Myers K, Hersey P. Polymerase chain reaction detection of melanoma cells in the circulation: Relation to clinical stage, surgical treatment, and recurrence from melanoma. J Clin Oncol 1998; 16: 1760-9.
28. Chen YT, Stockert E, Jungbluth A et al. Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proc Natl Acad Sci USA 1996; 93: 5915-19.
29. Coulie PG, van Brichard V, Pel A et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994; 180: 35-42.
30. Kawakami Y, Eliyabu S, Delgado CH et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994; 91: 3515-19.
31. Kawakami Y, Battles JK, Kobayashi T et al. Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: Use in the characterization of the human melanoma antigen MART-1. J Immunol Methods 1997; 202: 13-25.